MARTORA, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 604
NA - Nord America 454
AS - Asia 298
AF - Africa 8
SA - Sud America 3
OC - Oceania 1
Totale 1.368
Nazione #
US - Stati Uniti d'America 445
DE - Germania 413
SG - Singapore 227
IT - Italia 101
CN - Cina 33
FI - Finlandia 32
IN - India 22
RU - Federazione Russa 11
IE - Irlanda 10
ES - Italia 8
FR - Francia 7
CI - Costa d'Avorio 6
MX - Messico 6
JP - Giappone 5
NL - Olanda 5
RS - Serbia 5
GB - Regno Unito 4
EE - Estonia 3
HK - Hong Kong 3
BR - Brasile 2
CA - Canada 2
ID - Indonesia 2
IL - Israele 2
PK - Pakistan 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
MA - Marocco 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.368
Città #
Santa Clara 201
Singapore 188
Krefeld 113
Bad Bellingen 50
Ashburn 31
Munich 23
Naples 22
Lappeenranta 18
Helsinki 14
Rome 12
Seattle 12
Dublin 10
Milan 8
Kronberg 7
Los Angeles 6
Pune 6
Kochi 5
Turin 5
Boardman 4
Council Bluffs 4
Florence 4
Mexico City 4
Qingdao 4
Xi'an 4
Zhengzhou 4
Arezzo 3
Castellammare di Stabia 3
Freiburg im Breisgau 3
New Delhi 3
Nuremberg 3
Roccasecca 3
Rottweil 3
Tallinn 3
Tokyo 3
Amsterdam 2
Angri 2
Bad Durrheim 2
Bhundsi 2
Chennai 2
Corteolona 2
Formia 2
Jakarta 2
Lecce 2
London 2
Moscow 2
Mumbai 2
New York 2
Newark 2
Paris 2
Pescara 2
San Nicolás de los Garza 2
Sarno 2
Schoenwalde 2
Shenzhen 2
Sialkot 2
Treviso 2
Utsunomiya 2
Affing 1
Belgrade 1
Bolton 1
Boulder 1
Brussels 1
Caivano 1
Camisano Vicentino 1
Chicago 1
Cologne 1
Copenhagen 1
Coquitlam 1
Dallas 1
Delhi 1
Fisciano 1
Gallatin 1
Gorgonzola 1
Guayaquil 1
Hachenburg 1
Hong Kong 1
Kunming 1
Madrid 1
Mariglianella 1
Nanjing 1
Oran 1
Perth 1
Portland 1
Porto Alegre 1
Rabat 1
Riyadh 1
Saint-Martin-d'Hères 1
Salerno 1
San José 1
Sant'Anastasia 1
Seville 1
São Paulo 1
Tel Aviv 1
Tianjin 1
Tirana 1
Victoria 1
Wilmington 1
Yinchuan 1
Totale 873
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 325
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis 63
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis 33
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 32
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 25
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 24
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 23
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 22
Efficacy and Safety of bimekizumab in psoriasis management in real-life: bio-naïve vs bio-experienced 22
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 21
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation 20
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 20
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 18
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data 18
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis 18
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study 18
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab" 18
Herpes Zoster and COVID-19 Vaccination: A Narrative Review 17
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study 17
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection 17
Comment on: "Associations between hidradenitis suppurativa and dermatological conditions in adults: A national cross-sectional study by Brown et al." 17
Risk Factors for Psoriasis Flares: A Narrative Review 16
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials 16
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting 16
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis 15
Comment on ‘Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine’ 15
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature 15
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 15
Oral Minoxidil for Chemotherapy-Induced Alopecia 15
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab 15
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 14
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler 14
Reply to 'Omalizumab for the management of refractory aquagenic pruritus' 14
ChatGPT and Dermatology: friends or foes? 13
Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511” 13
Management of Psoriasis Patients with Serious Infectious Diseases 13
Guselkumab-induced vitiligo in a patient with psoriatic arthritis 13
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al 13
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 13
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 13
Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa” 13
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 13
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Duff et al 12
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 12
Unaddressed Challenges in the Treatment of Cutaneous Melanoma? 12
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review 12
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 12
ChatGPT and dermatology 12
Advancing Dermatology: Embracing the Power of Artificial Intelligence 12
Airborne allergic contact dermatitis "by proxy" due to budesonide 12
An update on the current and emerging pharmacotherapies for basal cell carcinomas 12
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study 12
The Past, the Present and the Future of Teledermatology: A Narrative Review 12
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States' 11
Comment on ‘Permethrin-unresponsive scabies in London, UK: a wake-up call’ 11
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19 11
Comment on ‘Anogenital dermatology: challenges in the digital era’ 11
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature 10
Dietary intervention in acne management: review of the literature and future prospective 10
Lichen planus following Covid-19 vaccination: a narrative review 10
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation 10
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities 10
Allergic contact dermatitis to petrolatum: An unknown for patch testing 9
Comment on ‘Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination’ 9
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report 9
Comment on ‘Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease’ 9
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report 9
Management of Advanced Invasive Melanoma: New Strategies 9
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study 9
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation 8
Reply to “Dalbavancin for the treatment of severe hidradenitis suppurativa” 8
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review 8
ChatGPT and Medical Writing in Dermatology: why should we keep writing? 7
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study 7
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study 7
Reply to ‘Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativa’ by Holgersen et al 7
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 7
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter] 6
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments 6
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature 6
Comment on ‘Oral ivermectin to treat scabies: a comparison of two different regimens’ 4
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective study 3
Climate change and the role of dermatologists: a call to action 2
The use of ChatGPT in the dermatological field: a narrative review 2
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 2
Totale 1.464
Categoria #
all - tutte 9.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202383 0 0 0 0 0 10 11 17 3 16 17 9
2023/2024720 13 22 50 18 11 24 16 42 331 40 77 76
2024/2025661 104 158 35 31 79 237 17 0 0 0 0 0
Totale 1.464